<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>IUIS classification of congenital defects of phagocyte number or function (category V inborn errors of immunity)</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">IUIS classification of congenital defects of phagocyte number or function (category V inborn errors of immunity)</h1>
<div class="graphic"><div class="figure"><div class="ttl">IUIS classification of congenital defects of phagocyte number or function (category V inborn errors of immunity)</div><div class="cntnt"><table cellspacing="0"><colgroup span="7" width="14%"></colgroup> <tbody> <tr> <td class="subtitle1">Disease</td> <td class="subtitle1">Genetic defect</td> <td class="subtitle1">Inheritance</td> <td class="subtitle1">OMIM</td> <td class="subtitle1">Affected cells</td> <td class="subtitle1">Affected function</td> <td class="subtitle1">Associated features</td> </tr> <tr> <td class="subtitle2_left" colspan="7">Congenital neutropenias</td> </tr> <tr> <td class="indent1">Elastase deficiency (SCN1)</td> <td>Elastase, neutrophil expressed (<em>ELANE</em>)</td> <td>AD</td> <td><a href="https://www.omim.org/entry/130130">130130</a></td> <td>Neutrophils</td> <td>Myeloid differentiation</td> <td>Susceptibility to MDS/leukemia; SCN or cyclic neutropenia</td> </tr> <tr> <td class="indent1">GFI1 deficiency (SCN2)</td> <td>Growth factor independent 1 transcriptional repressor (<em>GFI1</em>)</td> <td>AD</td> <td><a href="https://www.omim.org/entry/600871">600871</a></td> <td>Neutrophils</td> <td>Myeloid differentiation</td> <td>B/T lymphopenia</td> </tr> <tr> <td class="indent1">HAX1 deficiency (Kostmann disease; SCN3)</td> <td>HCLS1-associated protein X-1 (<em>HAX1</em>)</td> <td>AR</td> <td><a href="https://www.omim.org/entry/605998">605998</a></td> <td>Neutrophils</td> <td>Myeloid differentiation</td> <td>Cognitive and neurologic defects in patients with defects in both HAX1 isoforms, susceptibility to MDS/leukemia</td> </tr> <tr> <td class="indent1">G6PC3 deficiency (SCN4)</td> <td>Glucose-6-phosphatase catalytic subunit 3 (<em>G6PC3</em>)</td> <td>AR</td> <td><a href="https://www.omim.org/entry/611045">611045</a></td> <td>Neutrophils</td> <td>Myeloid differentiation, chemotaxis, O<sub>2</sub><sup>+</sup> production</td> <td>Structural heart defects, urogenital abnormalities, inner ear dearness, venous angiectasias of the trunk and limbs</td> </tr> <tr> <td class="indent1">VPS45 deficiency (SCN5)</td> <td>Vacuolar protein sorting 45 homolog (<em>VPS45</em>)</td> <td>AR</td> <td><a href="https://www.omim.org/entry/610035">610035</a></td> <td>Neutrophils</td> <td>Myeloid differentiation, migration</td> <td>Extramedullary hematopoiesis, bone marrow fibrosis, nephromegaly</td> </tr> <tr> <td class="indent1">Glycogen storage disease type 1b</td> <td>Solute carrier family 37 member 4 (<em>SLC37A4</em>)</td> <td>AR</td> <td><a href="https://www.omim.org/entry/602671">602671</a></td> <td>Neutrophils, monocytes</td> <td>Myeloid differentiation, chemotaxis, O<sub>2</sub><sup>+</sup> production</td> <td>Fasting hypoglycemia, lactic acidosis, hyperlipidemia, hepatomegaly</td> </tr> <tr> <td class="indent1">X-linked neutropenia/myelodysplasia</td> <td>WASP actin nucleation promoting factor (<em>WAS</em>)</td> <td>XL GOF</td> <td><a href="https://www.omim.org/entry/300299">300299</a></td> <td>Neutrophils</td> <td>Differentiation, mitosis; results from GOF mutations in GTPase binding domain of WASp</td> <td>Neutropenia, myeloid maturation arrest, monocytopenia, variable lymphoid anomalies</td> </tr> <tr> <td class="indent1">P14/LAMTOR2 deficiency</td> <td>Late endosomal/lysosomal adaptor, MAPK and MTOR activator 2 (<em>LAMTOR2</em>)</td> <td>AR</td> <td><a href="https://www.omim.org/entry/610389">610389</a></td> <td>Neutrophils, monocytes</td> <td>Endosomal biogenesis</td> <td>Neutropenia, hypogammaglobulinemia, reduced CD8 cytotoxicity, partial albinism, growth failure</td> </tr> <tr> <td class="indent1">Barth syndrome (3-methylglutaconic aciduria type II)</td> <td>Tafazzin, phospholipid-lysophospholipid transacylase (<em>TAFAZZIN</em>)</td> <td>XL</td> <td><a href="https://www.omim.org/entry/300394">300394</a></td> <td>Neutrophils, lymphocytes, melanocytes</td> <td>Mitochondrial function</td> <td>Cardiomyopathy, myopathy, growth retardation, neutropenia</td> </tr> <tr> <td class="indent1">Cohen syndrome</td> <td>Vacuolar protein sorting 13 homolog B (<em>VPS13B</em>)</td> <td>AR</td> <td><a href="https://www.omim.org/entry/607817">607817</a></td> <td>Neutrophils</td> <td>Myeloid differentiation</td> <td>Dysmorphism, intellectual disability, obesity, deafness, neutropenia</td> </tr> <tr> <td class="indent1">Clericuzio syndrome (poikiloderma with neutropenia)</td> <td>U6 snRNA biogenesis phosphodiesterase 1 (<em>USB1</em>)</td> <td>AR</td> <td><a href="https://www.omim.org/entry/613276">613276</a></td> <td>Neutrophils</td> <td>Myeloid differentiation</td> <td>Retinopathy, developmental delay, facial dysmorphisms, poikiloderma</td> </tr> <tr> <td class="indent1">JAGN1 deficiency</td> <td>Jagunal homolog 1 (<em>JAGN1</em>)</td> <td>AR</td> <td><a href="https://www.omim.org/entry/616012">616012</a></td> <td>Neutrophils</td> <td>Myeloid differentiation</td> <td>Myeloid maturation arrest, osteopenia</td> </tr> <tr> <td class="indent1">3-methylglutaconic aciduria</td> <td>Caseinolytic mitochondrial matrix peptidase chaperone subunit B (<em>CLPB</em>)</td> <td>AR</td> <td><a href="https://www.omim.org/entry/616254">616254</a></td> <td>Neutrophils</td> <td>Myeloid differentiation, mitochondrial protein</td> <td>Neurocognitive developmental aberrations, microcephaly, hypoglycemia, hypotonia, ataxia, seizures, cataracts, IUGR</td> </tr> <tr> <td class="indent1">G-CSF receptor deficiency</td> <td>Colony-stimulating factor 3 receptor (<em>CSF3R</em>)</td> <td>AR</td> <td><a href="https://www.omim.org/entry/138971">138971</a></td> <td>Neutrophils</td> <td>Stress granulopoiesis disturbed</td> <td> </td> </tr> <tr> <td class="indent1">SMARCD2 deficiency</td> <td>SWI/SNF-related, matrix-associated, actin-dependent regulator of chromatin, subfamily d, member 2 (<em>SMARCD2</em>)</td> <td>AR</td> <td><a href="https://www.omim.org/entry/601736">601736</a></td> <td>Neutrophils</td> <td>Chromatin remodeling, myeloid differentiation, neutrophil functional defect</td> <td>Neutropenia, developmental aberrations, bones, HSCs, myelodysplasia</td> </tr> <tr> <td class="indent1">Specific granule deficiency</td> <td>CCAAT enhancer-binding protein epsilon <em>(CEBPE</em>)</td> <td>AR</td> <td><a href="https://www.omim.org/entry/189965">189965</a></td> <td>Neutrophils</td> <td>Terminal maturation and global dysfunction</td> <td>Neutropenia, neutrophils with bilobed nuclei</td> </tr> <tr> <td class="indent1" rowspan="3">Schwachman-Diamond syndrome</td> <td>SBDS ribosome maturation factor <em>(SBDS</em>)</td> <td>AR</td> <td><a href="https://www.omim.org/entry/607444">607444</a></td> <td>Neutrophils</td> <td>Neutrophil maturation, chemotaxis, ribosomal biogenesis</td> <td>Pancytopenia, exocrine pancreatic insufficiency, chondrodysplasia</td> </tr> <tr> <td>DnaJ heat-shock protein family (Hsp40) member C21 (<em>DNAJC21</em>)</td> <td>AR</td> <td><a href="https://www.omim.org/entry/617052">617052</a></td> <td>Neutrophils, HSCs</td> <td>Neutrophil maturation, chemotaxis, ribosomal biogenesis</td> <td>Pancytopenia, exocrine pancreatic insufficiency</td> </tr> <tr> <td>Elongation factor-like GTPase 1 (<em>EFL1</em>)</td> <td>AR</td> <td><a href="https://www.omim.org/entry/617941">617941</a></td> <td>Neutrophils, HSCs</td> <td>Neutrophil maturation, chemotaxis, ribosomal biogenesis</td> <td>Pancytopenia, exocrine pancreatic insufficiency</td> </tr> <tr> <td class="indent1">HYOU1 deficiency</td> <td>Hypoxia upregulated 1 (<em>HYOU1</em>)</td> <td>AR</td> <td><a href="https://www.omim.org/entry/601746">601746</a></td> <td>Neutrophils</td> <td>Unfolded protein response</td> <td>Hypoglycemia, inflammatory complications</td> </tr> <tr> <td class="indent1">SRP54 deficiency</td> <td>Signal recognition particle 54 (<em>SRP54</em>)</td> <td>AD</td> <td><a href="https://www.omim.org/entry/604857">604857</a></td> <td>Neutrophils</td> <td>Protein translocation to ER, myeloid differentiation, neutrophil functional defect</td> <td>Neutropenia, exocrine pancreatic insufficiency</td> </tr> <tr> <td class="indent1">CXCR2 deficiency</td> <td>C-X-C motif chemokine receptor 2 (<em>CXCR2</em>)</td> <td>AR</td> <td><a href="https://www.omim.org/entry/619407">619407</a></td> <td>Neutrophils</td> <td>Reduced expression of CXCR2 on patient cells, impaired responses to CXCL8</td> <td>Profound neutropenia, myelokathexis, recurrent gingivitis, oral ulcers, hypergammaglobulinemia</td> </tr> <tr> <td class="subtitle2_left" colspan="7">Defects of motility</td> </tr> <tr> <td class="indent1">Leukocyte adhesion deficiency type 1 (LAD1)</td> <td>Integrin subunit beta 1 (<em>ITGB1</em>)</td> <td>AR</td> <td><a href="https://www.omim.org/entry/600065">600065</a></td> <td>Neutrophils, monocytes, lymphocytes, NK cells</td> <td>Adherence, chemotaxis, endocytosis, T/NK cytotoxicity</td> <td>Delayed cord separation, skin ulcers, periodontitis, leukocytosis</td> </tr> <tr> <td class="indent1">Leukocyte adhesion deficiency type 2 (LAD2)</td> <td>Solute carrier family 35 member C1 (<em>SLC35C1</em>)</td> <td>AR</td> <td><a href="https://www.omim.org/entry/605881">605881</a></td> <td>Neutrophils, monocytes</td> <td>Rolling, chemotaxis</td> <td>Mild LAD1 features with hh-blood group, growth retardation, developmental delay</td> </tr> <tr> <td class="indent1">Leukocyte adhesion deficiency type 3 (LAD3)</td> <td>FERM domain-containing kindlin 3 (<em>FERMT3</em>)</td> <td>AR</td> <td><a href="https://www.omim.org/entry/607901">607901</a></td> <td>Neutrophils, monocytes, lymphocytes, NK cells</td> <td>Adherence, chemotaxis</td> <td>LAD1 plus bleeding tendency</td> </tr> <tr> <td class="indent1">Rac2 deficiency</td> <td>Rac family small GTPase 2 (<em>RAC2</em>)</td> <td>AD LOF</td> <td><a href="https://www.omim.org/entry/608203">608203</a></td> <td>Neutrophils</td> <td>Adherence, chemotaxis, O<sub>2</sub><sup>+</sup> production</td> <td>Poor wound healing, leukocytosis</td> </tr> <tr> <td class="indent1">Beta actin deficiency</td> <td>Actin beta <em>(ACTB</em>)</td> <td>AD</td> <td><a href="https://www.omim.org/entry/102630">102630</a></td> <td>Neutrophils, monocytes</td> <td>Motility</td> <td>Intellectual disability, short stature</td> </tr> <tr> <td class="indent1">Localized juvenile periodontitis</td> <td>Formyl peptide receptor 1 (<em>FPR1</em>)</td> <td>AR</td> <td><a href="https://www.omim.org/entry/136537">136537</a></td> <td>Neutrophils</td> <td>Formylpeptide-induced chemotaxis</td> <td>Periodontitis only</td> </tr> <tr> <td class="indent1">Papillon-Lefèvre syndrome</td> <td>Cathepsin C (<em>CTSC</em>)</td> <td>AR</td> <td><a href="https://www.omim.org/entry/602365">602365</a></td> <td>Neutrophils, monocytes</td> <td>Chemotaxis</td> <td>Periodontitis, palmoplantar hyperkeratosis in some patients</td> </tr> <tr> <td class="indent1">WDR1 deficiency</td> <td>WD repeat domain 1 (<em>WDR1</em>)</td> <td>AR</td> <td><a href="https://www.omim.org/entry/604734">604734</a></td> <td>Neutrophils</td> <td>Spreading, survival, chemotaxis</td> <td>Mild neutropenia, poor wound healing, severe stomatitis, neutrophil nuclei herniate</td> </tr> <tr> <td class="indent1">Cystic fibrosis</td> <td>CF transmembrane conductance regulator (<em>CFTR</em>)</td> <td>AR</td> <td><a href="https://www.omim.org/entry/602421">602421</a></td> <td>Monocytes only</td> <td>Chemotaxis</td> <td>Respiratory infections, pancreatic insufficiency, elevated sweat chloride</td> </tr> <tr> <td class="indent1">Neutropenia with combined immunodeficiency due to MKL1 deficiency</td> <td>Megakaryoblastic leukemia (translocation) 1 (<em>MKL1</em>)</td> <td>AR</td> <td><a href="https://www.omim.org/entry/606078">606078</a></td> <td>Neutrophils, monocytes, lymphocytes, NK cells</td> <td>Impaired expression of cytoskeletal genes</td> <td>Mild thrombocytopenia</td> </tr> <tr> <td class="subtitle2_left" colspan="7">Defects of respiratory burst</td> </tr> <tr> <td class="indent1">XL chronic granulomatous disease (CGD), gp91phox</td> <td>Cytochrome b-245 beta chain (<em>CYBB</em>)</td> <td>XL</td> <td><a href="https://www.omim.org/entry/306400">306400</a></td> <td>Neutrophils, monocytes</td> <td>Killing (faulty O<sub>2</sub><sup>+ </sup>production)</td> <td>Infections, autoinflammatory phenotype, IBD; McLeod phenotype in patients with deletions extending into the contiguous Kell locus</td> </tr> <tr> <td class="indent1" rowspan="5">AR CGD</td> <td>Cytochrome b-245 alpha chain (<em>CYBA</em>)</td> <td>AR</td> <td><a href="https://www.omim.org/entry/608508">608508</a></td> <td>Neutrophils, monocytes</td> <td>Killing (faulty O<sub>2</sub><sup>+ </sup>production)</td> <td>Infections, autoinflammatory phenotype</td> </tr> <tr> <td>Cytochrome b-245 chaperone 1 (<em>CYBC1</em>)</td> <td>AR</td> <td><a href="https://www.omim.org/entry/618334">618334</a></td> <td>Neutrophils, monocytes</td> <td>Killing (faulty O<sub>2</sub><sup>+ </sup>production)</td> <td>Infections, autoinflammatory phenotype</td> </tr> <tr> <td>Neutrophil cytosolic factor 1 (<em>NCF1</em>)</td> <td>AR</td> <td><a href="https://www.omim.org/entry/608512">608512</a></td> <td>Neutrophils, monocytes</td> <td>Killing (faulty O<sub>2</sub><sup>+ </sup>production)</td> <td>Infections, autoinflammatory phenotype</td> </tr> <tr> <td>Neutrophil cytosolic factor 2 (<em>NCF2</em>)</td> <td>AR</td> <td><a href="https://www.omim.org/entry/608515">608515</a></td> <td>Neutrophils, monocytes</td> <td>Killing (faulty O<sub>2</sub><sup>+ </sup>production)</td> <td>Infections, autoinflammatory phenotype</td> </tr> <tr> <td>Neutrophil cytosolic factor 4 (<em>NCF4</em>)</td> <td>AR</td> <td><a href="https://www.omim.org/entry/613960">613960</a></td> <td>Neutrophils, monocytes</td> <td>Killing (faulty O<sub>2</sub><sup>+ </sup>production)</td> <td>Infections, autoinflammatory phenotype</td> </tr> <tr> <td class="indent1">G6PD deficiency class I</td> <td>Glucose-6-phosphate dehydrogenase (<em>G6PD</em>)</td> <td>XL</td> <td><a href="https://www.omim.org/entry/305900">305900</a></td> <td>Neutrophils</td> <td>Reduced O<sub>2</sub><sup>-</sup> production</td> <td>Infections</td> </tr> <tr> <td class="subtitle2_left" colspan="7">Other nonlymphoid defects</td> </tr> <tr> <td class="indent1">GATA2 deficiency</td> <td>GATA-binding protein 2 (<em>GATA2</em>)</td> <td>AD</td> <td><a href="https://www.omim.org/entry/137295">137295</a></td> <td>Monocytes, peripheral DCs</td> <td>Multilineage cytopenias</td> <td>Susceptibility to mycobacterial, HPV, histoplasmosis, alveolar proteinosis, MDS/AML/CMML, lymphedema</td> </tr> <tr> <td class="indent1" rowspan="2">Pulmonary alveolar proteinosis</td> <td>Colony-stimulating factor 2 receptor subunit alpha (<em>CSF2RA</em>)</td> <td>XL (biallelic mutations in pseudoautosomal gene)</td> <td><a href="https://www.omim.org/entry/300770">300770</a></td> <td>Alveolar macrophages</td> <td>GM-CSF signaling</td> <td>Alveolar proteinosis</td> </tr> <tr> <td>Colony-stimulating factor 2 receptor subunit beta (<em>CSF2RB</em>)</td> <td>AR</td> <td><a href="https://www.omim.org/entry/614370">614370</a></td> <td>Alveolar macrophages</td> <td>GM-CSF signaling</td> <td>Alveolar proteinosis</td> </tr> </tbody></table></div><div class="graphic_lgnd">Total number of mutant genes in table: 42.</div><div class="graphic_footnotes">IUIS: International Union of Immunological Societies; SCN: severe congenital neutropenia; AD: autosomal dominant; MDS: myelodysplastic syndrome; AR: autosomal recessive; XL: X linked; GOF: gain of function; WASp: Wiskott-Aldrich syndrome protein; CD: cluster of differentiation; snRNA: small nucleoside ribonucleic acid; IUGR: intrauterine growth restriction, G-CSF: granulocyte colony-stimulating factor; HSC: hematopoietic stem cell; ER: endoplasmic reticulum; CXCL8: C-X-C motif chemokine ligand 8; NK: natural killer; LOF: loss of function; IBD: inflammatory bowel disease; DC: dendritic cell; HPV: human papillomavirus; AML: acute myeloid leukemia; CMML: chronic myelomonocytic leukemia; GM-CSF: granulocyte-macrophage colony-stimulating factor.</div><div class="graphic_reference">From: Tangye SG, Al-Herz W, Bousfiha A, et al. Human inborn errors of immunity: 2022 update on the classification from the International Union of Immunological Societies Expert Committee. J Clin Immunol 2022; 42:1473. Copyright © 2022 The Authors. Reproduced under the terms of the <a href="https://creativecommons.org/licenses/by/4.0/" target="_blank">Creative Commons Attribution License 4.0</a>.</div><div id="graphicVersion">Graphic 139974 Version 1.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
